GlassScriptPhysician profile
Joseph S Murphy
NPI 1871698316
$11,692.82
in general payments reported to CMS, 2019-2025
60 companies · $2,262 in 2025
The $2,262 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,970 · 2020: $808 · 2021: $1,776 · 2022: $1,201 · 2023: $1,517 · 2024: $2,160 · 2025: $2,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,939.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,471.66 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,234.76 | 2019-2025 | |
| Pfizer INC. | $1,038.11 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $937.97 | 2019-2025 | Spravato, Xarelto |
| Amgen INC. | $524.04 | 2019-2025 | Otezla, Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $513.67 | 2019-2024 | Farxiga |
| Abbott Laboratories | $458.26 | 2021-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit |
| Otsuka America Pharmaceutical, INC. | $416.41 | 2022-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $383.70 | 2019-2025 | Xifaxan, Cycloset |
| Heartflow, INC. | $291.87 | 2024-2025 | |
| Lilly USA, LLC | $276.54 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Allergan, INC. | $251.79 | 2019-2020 | |
| Glaxosmithkline, LLC. | $251.78 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Cleerly, INC. | $248.44 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Takeda Pharmaceuticals U.S.A., INC. | $238.78 | 2019-2024 | Trintellix |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $231.46 | 2024-2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $226.94 | 2022-2024 | Quviviq |
| Astellas Pharma US INC | $217.53 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $216.58 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Sanofi-Aventis U.S. LLC | $186.68 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $180.60 | 2021-2023 | Eliquis, Camzyos |
| Viiv Healthcare Company | $147.65 | 2024-2025 | Apretude |
| Kowa Pharmaceuticals America, INC. | $126.64 | 2020-2025 | Zoryve |
| Supernus Pharmaceuticals, INC. | $114.68 | 2023 | Qelbree |
| Abiomed | $113.20 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $93.92 | 2020-2021 | |
| Stryker Corporation | $86.84 | 2023 | 7 X 23mm Citrelock Implant |
| Amarin Pharma, INC. | $84.83 | 2019-2022 | |
| Dexcom, INC. | $79.30 | 2020-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Aytu Biopharma, INC. | $74.44 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $71.90 | 2022 | |
| Exact Sciences Corporation | $69.36 | 2024-2025 | Cologuard Collection Kit |
| Corium, LLC | $63.93 | 2023 | Azstarys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.59 | 2023-2025 | Jardiance |
| Seqirus USA INC | $50.04 | 2023-2025 | Flucelvax, Fluad, Fluad Quadrivalent |
| Genentech USA, INC. | $48.94 | 2019-2022 | |
| Madrigal Pharmaceuticals | $48.74 | 2025 | Rezdiffra |
| Sanofi Pasteur INC. | $44.74 | 2019-2025 | |
| Corcept Therapeutics | $43.93 | 2025 | Korlym |
| Becton, Dickinson and Company | $35.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.00 | 2021-2025 | |
| Hologic Sales and Service, LLC | $33.78 | 2025 | Aptima |
| Novartis Pharmaceuticals Corporation | $32.12 | 2024 | |
| Coloplast Corp | $31.12 | 2019 | |
| Verity Pharmaceuticals INC. | $29.55 | 2024 | Tlando |
| Optos, INC. | $28.52 | 2020-2021 | |
| Boston Scientific Corporation | $25.54 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Eisai INC. | $24.24 | 2019-2020 | |
| Optinose US, INC. | $23.73 | 2022 | |
| Neos Therapeutics, LP | $20.90 | 2020 | |
| Dynavax Technologies Corporation | $20.38 | 2023 | Heplisav-B |
| Philips North America LLC | $18.41 | 2024 | (Ck7) Extended Holter |
| Lundbeck LLC | $17.97 | 2025 | Rexulti |
| Cardiovascular Systems INC. | $17.55 | 2020 | |
| Noven Therapeutics, LLC | $17.47 | 2024 | Secuado |
| Biocryst US Sales Co., LLC | $16.38 | 2021 | |
| Mdd US Operations, LLC | $14.18 | 2019 | |
| Esperion Therapeutics, INC. | $13.99 | 2024 | Nexletol |
| Jazz Pharmaceuticals INC. | $13.94 | 2020 | |
| Ironwood Pharmaceuticals, INC | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.